Skip to search formSkip to main contentSkip to account menu

Diffuse Large B-Cell Lymphoma

Known as: large cell diffuse lymphoma, DLBCL, Lymphoma, Diffuse Large Cell 
A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes. It is the most frequently seen type… 
National Institutes of Health

Related topics

Related topics

38 relations

Narrower (4)

Anaplastic LymphomaAngioendotheliomatosisMalignant lymphoma centroblastic, diffuseT-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Atypical lymphocyteB lymphoblastB-Cell Lymphoma 6 ProteinB-Lymphocytes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is a heterogenous class of aggressive lymphoma and is considered as the most common subtype… 
Review
2015
Review
2015
B-cell receptor signaling in diffuse large B-cell lymphoma.
The importance of understanding the genetic and biochemical basis of B-cell receptor (BCR) survival signaling in diffuse large B… 
Highly Cited
2013
Highly Cited
2013
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from…
Diffuse large B-cell lymphoma (DLBCL) is stratified into prognostically favorable germinal center B-cell (GCB)-like and… 
Highly Cited
2011
Highly Cited
2011
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.
PURPOSE Patients with diffuse large B-cell lymphoma (DLBCL) can be divided into prognostic groups based on the cell of origin of… 
Review
2010
Review
2010
B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements, also known as “double-hit” lymphomas (DHL), are rare neoplasms… 
Highly Cited
2007
Highly Cited
2007
Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
PURPOSE To study the clinical significance of transformation to diffuse large B-cell lymphoma (DLBCL) in patients with follicular… 
Highly Cited
2007
Highly Cited
2007
The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma.
To define prognostic impact of Epstein-Barr virus (EBV) infection in diffuse large B-cell lymphoma (DLBCL), we investigated EBV… 
Highly Cited
2005
Highly Cited
2005
Accumulation of miR-155 and BIC RNA in human B cell lymphomas.
We show that the microRNA miR-155 can be processed from sequences present in BIC RNA, a spliced and polyadenylated but non… 
Highly Cited
2005
Highly Cited
2005
BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas
In a previous study we demonstrated high expression of the non‐coding BIC gene in the vast majority of Hodgkin's lymphomas (HLs… 
Highly Cited
2003
Highly Cited
2003
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
Mediastinal large B-cell lymphoma (MLBCL) is a recently identified subtype of diffuse large B-cell lymphoma (DLBCL) that… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)